Today NYSE Liffe, the Europe-based derivatives business of NYSE Euronext (NYX), announced that it will add
options on the shares of Aperam (ticker symbol: APAM) to its highly successful range of equity option
classes. The launch of these options follows the successful listing of Aperam, the demerged stainless,
electrical and specialty steel activities of ArcelorMittal, which took place on January 26. On the same day
Aperam was also included in the AEX-index. The Aperam options will be introduced on the Amsterdam derivatives
market of NYSE Liffe.
Alan van Griethuysen, Business Head Benelux and Asia of NYSE Liffe commented: “With the listing of options on
Aperam we are further expanding our equity option franchise on the central market. We are pleased investors
in Aperam will also have access to our liquid and highly competitive options market.”
These new American-style options will expire on the third Friday of the contract month and will have initial
lifetimes of one to twelve months. Each option will represent 100 shares in Aperam and will be cleared via
LCH.Clearnet SA. Liquidity in the options will be supported by marketmakers 323 Trading, Caerus and Kemp Trading. Trading will take place on LIFFE CONNECT.
In 2010, 175 million equity options were traded on NYSE Liffe. Almost 50% of this volume was traded on the
Amsterdam market. NYSE Liffe lists stock options (also known as individual equity options) on over 250
leading European companies via the Amsterdam, Belgian, London and Paris central order books.
